GrantGrant
PRIP Scheme — Second Call for Pharma and MedTech R&D
Government R&D assistance across early-stage, discovery and later-stage tracks.
2 views0 shares
Funding amount
Early-stage assistance up to ₹5 crore; NCE/NBE discovery assistance up to ₹50 crore
Scheme
Promotion of Research and Innovation in Pharma MedTech Sector — Component B
Open for
Eligible India-registered entities include public/private limited companies, LLPs and registered partnerships. Public limited companies have no matching allowed Entity Type tag.
Deadline
17 November 2026
About the Program
Second call includes a new NCE/NBE discovery track. Assistance is subject to scheme agreements; benefit-sharing terms should be reviewed.
Eligibility requirements
- Early-stage and discovery tracks: startups/MSMEs completing TRL 1–3. Later-stage: industry/startups/MSMEs completing TRL 4–6. Do not resubmit the same Round 1 project.
Offerings / Benefits
- Early-stage: no applicant co-funding for approved costs up to ₹1 crore; higher costs require contribution. Discovery: minimum 25% institutional-investor co-funding. Later-stage: ordinarily up to 35% of approved costs, with specified strategic exceptions.
Sectors supported
New medicines, complex generics, biosimilars and novel medical devices.PharmaBiotechnologyHealthcare & HealthTech
Selection process
- Early-stage/discovery applicants submit concept notes before invited detailed applications. Later-stage applicants submit detailed applications; technical assessment precedes approval.
Related funding opportunities
BIRAC E-YUVA and Innovation Fellowship Call 2026
National biotechnology fellowship call providing research funding, stipends, incubation and business mentoring to young innovators.
Interconnect Innovation Catalyst Program 2026 – Cohort 2
Twelve-month, equity-free fellowship offering up to ₹30 lakh to TRL 4+ biomedical innovators.
D.E.S.I.G.N. for BioE3 Challenge — October 2026, Category II
Indian innovators can win ₹1 lakh and pursue separate proof-of-concept funding.